Making a difference stories
The NIHR's mission is to improve the health and wealth of the nation. Our research accelerates the translation of discoveries into new treatments and supports growth of the UK economy.
Read about how our work is influencing care, and making a positive difference to people, and the economy.
Interactive digital interventions (IDIs) are effective for sexual health promotion and HIV prevention. They could be rolled out much more widely to complement school sex and relationships education and sexual health services.
NIHR researchers have shown that early cancer diagnosis rates can be improved in primary care by increasing symptom awareness and reducing referral delays. Their research has contributed to national guidance developed to support GPs’ decision making and improve cancer survival rates in the UK.
Researchers investigating the role of IBS-specific CBT have found that both telephone and web-based CBT helped patients to better manage their condition, reducing the severity of their symptoms and the impact of IBS on their lives compared with their usual treatment.
A study identifying key strategies to improve the influenza vaccination rate among people at risk of serious disease has informed guidelines used by general practitioners to plan and deliver their annual vaccination programmes.
The PARTNER2 study has confirmed that antiretroviral treatment for HIV reduces the risk of sexual transmission between gay male partners to zero.
NIHR researchers have shown that a surgical procedure for young children with cerebral palsy improves their mobility and quality of life. The procedure is now available to eligible children on the NHS as a result of this evidence.
The FINCH study has reported new evidence to inform the management of care home residents with dementia who experience faecal incontinence.
A multidisciplinary team of researchers based in Oxford, Tanzania and Uganda are testing novel diagnostic tools and strengthening local capacity to improve early diagnosis of blood cancers called lymphomas.
An NIHR-funded trial has shown that therapy helps people with dementia achieve everyday goals, and this is being rolled out to health and care providers.
An evaluation by NIHR-funded researchers of the widely accessed New Medicine Service pharmacy scheme found that it improved patients’ adherence to new medications and resulted in cost savings to the NHS of £558 million.